These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36249085)

  • 21. Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital.
    Kamath S; Kumar M; Sarkar N; Ahmed T; Sunder A
    Cureus; 2022 Jan; 14(1):e21054. PubMed ID: 35155019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation and Comparison of Mucormycosis Patients' Features Undergoing Functional Endoscopic Sinus Surgery Prior to and during the COVID-19 Pandemic: A Case-Control Study.
    Dehghanpisheh L; Eghbal M; Salari M; Shahriarirad R; Borzou N; Vatankhah P
    Int J Clin Pract; 2022; 2022():1248325. PubMed ID: 35693548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19-associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico.
    Guzmán-Castro S; Chora-Hernandez LD; Trujillo-Alonso G; Calvo-Villalobos I; Sanchez-Rangel A; Ferrer-Alpuin E; Ruiz-Jimenez M; Corzo-Leon DE
    Mycoses; 2022 Jan; 65(1):65-70. PubMed ID: 34674319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 and mucormycosis superinfection: the perfect storm.
    Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
    Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors, Clinical Manifestations, and Outcomes of COVID-19-Associated Mucormycosis and Other Opportunistic Fungal Infections.
    Kumar D; Ahmad F; Kumar A; Bishnoi M; Grover A; Rewri P
    Cureus; 2023 Sep; 15(9):e46289. PubMed ID: 37915866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
    Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
    Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 associated mucormycosis - An emerging threat.
    Chao CM; Lai CC; Yu WL
    J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucormycosis infection in patients with COVID-19: A systematic review.
    SeyedAlinaghi S; Karimi A; Barzegary A; Pashaei Z; Afsahi AM; Alilou S; Janfaza N; Shojaei A; Afroughi F; Mohammadi P; Soleimani Y; Nazarian N; Amiri A; Tantuoyir MM; Oliaei S; Mehraeen E; Dadras O
    Health Sci Rep; 2022 Mar; 5(2):e529. PubMed ID: 35252593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Evaluation of COVID-19 Associated Mucormycosis (CAM) and Non-COVID-19-associated Mucormycosis (non-CAM).
    Oruc E; Gulen TA; Turunc T; Ekici NY; Unal N
    J Coll Physicians Surg Pak; 2023 Feb; 33(2):153-157. PubMed ID: 36797623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review.
    Shah NN; Khan Z; Ahad H; Elderdery AY; Alomary MN; Atwah B; Alhindi Z; Alsugoor MH; Elkhalifa AME; Nabi S; Bashir SM; Yaqub T; Rather GA; Ansari MA
    J Infect Public Health; 2022 Nov; 15(11):1299-1314. PubMed ID: 36279686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic.
    Bhanuprasad K; Manesh A; Devasagayam E; Varghese L; Cherian LM; Kurien R; Karthik R; Deodhar D; Vanjare H; Peter J; Michael JS; Thomas M; Samuel P; Varghese GM
    Int J Infect Dis; 2021 Oct; 111():267-270. PubMed ID: 34450284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The hospitalization rate and clinical characteristics of mucormycosis prior and during COVID-19 pandemic: A single-center study.
    Estakhr M; Ghotbi Z; Rostamihosseinkhani M; Hooshmandi E; Janipour M; Ostovan VR; Fadakar N; Bazrafshan H; Bahrami Z; Rahimi-Jaberi A; Poursadeghfard M; Nazeri M; Kouhi P; Petramfar P; Izadi S; Barzegar Z; Nikzadeh E; Sasannia S; Arsang-Jang S; Tabrizi R; Khademi B; Kohandel-Shirazi M; Salehi MS; Ashjazadeh N; Khademi B; Ashraf MJ; Eilami O; Roudgari A; Moghaddami M; Zomorodian K; Badali H; Borhani-Haghighi A
    J Infect Dev Ctries; 2023 Jun; 17(6):791-799. PubMed ID: 37406065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Satellite Epidemic of Covid-19 Associated Mucormycosis in India: A Multi-Site Observational Study.
    Satija A; Anand T; Mukherjee A; Velamuri PS; Singh KJ; Das M; Josten K; Keche AY; Nagarkar NM; Gupta P; Himanshu D; Mistry SN; Patel JD; Rao P; Rohatgi S; Ghosh S; Hazra A; Kindo AJ; Annamalai R; Rudramurthy SM; Singh MP; Shameem M; Fatima N; Khambholja JR; Parikh S; Madkaikar M; Pradhan VD; Bhargava A; Mehata R; Arora RD; Tigga R; Banerjee G; Sonkar V; Malhotra HS; Kumar N; Patil R; Raut CG; Bhattacharyya K; Arthur P; Somu L; Srikanth P; Shah PB; Panda NK; Sharma D; Hasan W; Ahmed A; Bathla M; Solanki S; Doshi H; Kanani Y; Patel N; Shah Z; Tembhurne AK; Rajguru C; Sankhe LR; Chavan SS; Yadav RM; Panda S
    Mycopathologia; 2023 Oct; 188(5):745-753. PubMed ID: 37490256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Clinical Manifestations, Pattern of Involvement, and Surgical Outcomes in Patients with Post Covid-19 Head and Neck Mucormycosis Infection among Patients Admitted To Namazi Hospital, Shiraz, Iran (2021-2022).
    Nahaei M; Motazedian G; Mohammadi AA; Davarpanah MA; Yazdanpanahi P; Ayareh N; Salari F; Keshtkar A
    World J Plast Surg; 2023; 12(3):64-72. PubMed ID: 38226199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Second COVID-19 Wave Is a Tsunami With Aftershocks: Mucormycosis Ire as Seen in a Tertiary Care Hospital in Uttarakhand, India.
    Raina D; Rohilla R; Patwal S; Pandita A
    Cureus; 2023 Oct; 15(10):e47358. PubMed ID: 38021725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 associated mucormycosis (CAM) in Kashan, Iran: clinical presentations, risk factors, management, and outcomes.
    Erami M; Raiesi O; Momen-Heravi M; Mirhendi H; Aboutalebian S; Getso MI; Matini AH; Ahsaniarani AH; Ganjizadeh M; Hassani Josheghani H; Amiri S; Pakzad R; Hashemi SJ
    Infect Dis (Lond); 2024 Feb; 56(2):81-90. PubMed ID: 37816067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global Prevalence of COVID-19-Associated Mucormycosis (CAM): Living Systematic Review and Meta-Analysis.
    Hussain S; Riad A; Singh A; Klugarová J; Antony B; Banna H; Klugar M
    J Fungi (Basel); 2021 Nov; 7(11):. PubMed ID: 34829271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sinonasal mucormycosis during 2 years of COVID-19 pandemic in central Iran: incidence rate and clinical features.
    Dadgarnia M; Mandegari M; Baradaranfar M; Vaziribozorg S; Abdollahpour M
    Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(5):298-304. PubMed ID: 36966984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome.
    Sahu M; Shah M; Mallela VR; Kola VR; Boorugu HK; Punjani AAR; Kumar RV; Kumar S; Manusrut M; Kumar SCR; Rathod R; Babu DM; Gonuguntla HK; Yedlapati GK; Mallu GR; Reddy YS; Reddy VV; Alwala S; Bongu VK; Kamalesh A; Kumar RNK; Jaishetwar GS; Bagapally RS; Srinivas JS; Balasubramaniam A; Rajagopalan BK; Pullikanti B; Prakasham SP; Nimmala P; Nagaraju B; Sahoo PR;
    Infection; 2023 Apr; 51(2):407-416. PubMed ID: 35922704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.